Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Abstract

No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study.

Sally Aspegren Kendall, Malika Lone Chenoufi Schaadt, Lykke Bjerglund Graff, Irene Wittrup, Hanne Malmskov, Kim Krogsgaard, Else-Marie Bartels, Henning Bliddal and Bente Danneskiold-Samsøe
The Journal of Rheumatology April 2004, 31 (4) 783-784;
Sally Aspegren Kendall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malika Lone Chenoufi Schaadt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lykke Bjerglund Graff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Wittrup
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanne Malmskov
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim Krogsgaard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Else-Marie Bartels
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henning Bliddal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bente Danneskiold-Samsøe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

OBJECTIVE: To investigate the effect of an antiviral compound, valacyclovir, on pain and tenderness in patients with the fibromyalgia (FM) syndrome. METHODS: Sixty patients were randomized into a double blind, placebo controlled 6 week trial. Primary outcome was pain intensity change (on visual analog scale). Secondary outcome measures were tender points (myalgic score) and Fibromyalgia Impact Questionnaire (FIQ). RESULTS: Fifty-two patients completed the study. The numbers of dropouts due to adverse events were equal in valacyclovir (2) and placebo (2) groups. The effect of valacyclovir on pain and tenderness and FIQ did not differ from placebo. CONCLUSION: Valacyclovir cannot be recommended as a therapy for FM at this point.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 31, Issue 4
1 Apr 2004
  • Table of Contents
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study.
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study.
Sally Aspegren Kendall, Malika Lone Chenoufi Schaadt, Lykke Bjerglund Graff, Irene Wittrup, Hanne Malmskov, Kim Krogsgaard, Else-Marie Bartels, Henning Bliddal, Bente Danneskiold-Samsøe
The Journal of Rheumatology Apr 2004, 31 (4) 783-784;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study.
Sally Aspegren Kendall, Malika Lone Chenoufi Schaadt, Lykke Bjerglund Graff, Irene Wittrup, Hanne Malmskov, Kim Krogsgaard, Else-Marie Bartels, Henning Bliddal, Bente Danneskiold-Samsøe
The Journal of Rheumatology Apr 2004, 31 (4) 783-784;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire